Patient Navigator Program
患者导航程序
基本信息
- 批准号:7681052
- 负责人:
- 金额:$ 62.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-29 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanAgeAmerican Cancer SocietyBay RegionBiometryBreastCancer CenterCaringClient satisfactionClinicCommunitiesCommunity HealthCommunity HospitalsCommunity MedicineComprehensive Cancer CenterDataDiagnosisEarly DiagnosisEconomicsEducationEducational BackgroundEffectivenessEffectiveness of InterventionsEvaluationFloridaGoalsHealth PromotionHispanicsIncidenceInterventionKnowledgeLeadLifeLiving CostsMalignant NeoplasmsMedicalMetricMonitorOutcomeOutcome StudyParticipantPatientsPhasePopulation HeterogeneityPovertyPreparationProcessProgram SustainabilityProviderPsychologyPublic HealthPublic Health PracticeQuality of lifeRaceRandomizedRandomized Controlled TrialsResearchResearch InstituteScreening procedureSocietiesSurvival RateTimeTranslatingUnderserved PopulationWorkbasecancer carecancer health disparitycancer riskcancer therapycare systemscolorectal cancer screeningcostcost effectivenessdesignexpectationhigh schoolimprovedmembermortalityprogramsresearch and developmentsocioeconomics
项目摘要
DESCRIPTION (provided by applicant):
The elimination of cancer disparities is a national imperative that requires the creation of accessible and beneficial interventions. The Tampa Bay region of west central Florida epitomizes this challenge, with low levels of education (20% without a high school education), high levels of poverty (12.5% living below the poverty line), a culturally diverse population (18 percent Hispanic and 15 percent African American), and high cancer incidence and mortality rates. Our hypothesis is that a culturally appropriate patient navigator program can be implemented in the Tampa Bay region of Florida that .will decrease delay in diagnosis and delivery of cancer care in an acceptable and cost-effective manner. Our plan is based upon a partnership that includes an NCI designated comprehensive cancer center (H. Lee Moffitt Cancer Center & Research Institute), community hospitals and clinics, the American Cancer Society, and HealthChoice Network. In Phase I we will work closely with our community partners to conduct formative research for the development of an acceptable, appealing, and appropriate Patient Navigator Program/During Phase I we will also obtain baseline data, through chart abstraction, on timeliness and cost of cancer care. Phase II is a group randomized controlled trial to evaluate the Patient Navigator Program. We will focus on patients diagnosed with a breast or colorectal cancer screening abnormality within our participating network. Four centers will receive the Navigator Program, and three will receive the intervention, but delayed. Data will be collected at the time of an abnormal screening finding, and at 1 month, 6 month, 1 year and 2 years to monitor timeliness of care, appropriateness of care, and patient satisfaction and quality of life. Phase III calls for the dissemination of the findings from this research outside the Tampa Bay region. We will Use study outcome data, including results of cost-effectiveness analyses plus input from key stakeholders (participants and providers) to develop a plan for long-term dissemination and sustainability of the program. This study is expected to result in a comprehensive evaluation of a Patient Navigator Program on quality of cancer care, patient satisfaction, quality of life and cost-effectiveness. Such knowledge is essential to improvements in reducing the mortality and suffering from cancer by 2015
描述(由申请人提供):
消除癌症差距是国家的当务之急,需要创造可获得和有益的干预措施。佛罗里达州中西部的坦帕湾地区就是这一挑战的缩影,那里的教育水平低(20%没有高中教育),贫困程度高(12.5%生活在贫困线以下),人口文化多元化(18%是西班牙裔,15%是非裔美国人),癌症发病率和死亡率很高。我们的假设是,在佛罗里达州的坦帕湾地区,可以实施一种文化上合适的患者导航员计划,以可接受和经济高效的方式减少癌症诊断和治疗的延误。我们的计划基于合作伙伴关系,其中包括NCI指定的综合性癌症中心(H.Lee Moffitt癌症中心和研究所)、社区医院和诊所、美国癌症协会和HealthChoice Network。在第一阶段,我们将与我们的社区合作伙伴密切合作,进行形成性研究,以开发可接受、有吸引力和适当的患者导航计划/在第一阶段,我们还将通过图表摘要获得癌症护理的及时性和成本方面的基线数据。第二阶段是一组随机对照试验,用于评估患者导航器计划。我们将重点关注我们参与网络中被诊断为乳腺癌或结直肠癌筛查异常的患者。四个中心将接受导航员计划,三个中心将接受干预,但被推迟。在发现异常筛查时,以及在1个月、6个月、1年和2年收集数据,以监测护理的及时性、护理的适当性、患者的满意度和生活质量。第三阶段要求在坦帕湾地区以外的地区传播这项研究的结果。我们将使用研究结果数据,包括成本效益分析的结果,以及关键利益相关者(参与者和提供者)的投入来制定计划,以长期传播和维持该计划。这项研究预计将对患者导航员计划在癌症护理质量、患者满意度、生活质量和成本效益方面进行全面评估。这些知识对于在2015年前降低死亡率和罹患癌症方面的改进至关重要
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessing the impact of patient navigation: prevention and early detection metrics.
- DOI:10.1002/cncr.26267
- 发表时间:2011-08
- 期刊:
- 影响因子:6.2
- 作者:Battaglia TA;Burhansstipanov L;Murrell SS;Dwyer AJ;Caron SE;Prevention and Early Detection Workgroup, National Patient Navigation Leadership Summit
- 通讯作者:Prevention and Early Detection Workgroup, National Patient Navigation Leadership Summit
Application of geographic information systems and asset mapping to facilitate identification of colorectal cancer screening resources.
- DOI:10.5210/ojphi.v2i1.2893
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Gwede CK;Ward BG;Luque JS;Vadaparampil ST;Rivers D;Martinez-Tyson D;Noel-Thomas S;Meade CD
- 通讯作者:Meade CD
Patients, family caregivers, and patient navigators: a partnership approach.
- DOI:10.1002/cncr.26263
- 发表时间:2011-08-01
- 期刊:
- 影响因子:6.2
- 作者:Palos, Guadalupe R;Hare, Martha
- 通讯作者:Hare, Martha
Lay navigator model for impacting cancer health disparities.
- DOI:10.1007/s13187-014-0640-z
- 发表时间:2014-09
- 期刊:
- 影响因子:0
- 作者:Meade CD;Wells KJ;Arevalo M;Calcano ER;Rivera M;Sarmiento Y;Freeman HP;Roetzheim RG
- 通讯作者:Roetzheim RG
History and principles of patient navigation.
- DOI:10.1002/cncr.26262
- 发表时间:2011-08
- 期刊:
- 影响因子:6.2
- 作者:Freeman HP;Rodriguez RL
- 通讯作者:Rodriguez RL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD G ROETZHEIM其他文献
RICHARD G ROETZHEIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD G ROETZHEIM', 18)}}的其他基金
A COMMUNITY INTERVENTION TO PROMOTE CANCER SCREENING
促进癌症筛查的社区干预
- 批准号:
2909197 - 财政年份:1999
- 资助金额:
$ 62.19万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 62.19万 - 项目类别:
Research Grant